Literature DB >> 11004471

A re-examination of the structural and functional consequences of mutation of alanine-128 of the b subunit of Escherichia coli ATP synthase to aspartic acid.

S D Dunn1, Y Bi, M Revington.   

Abstract

The effects of mutation of residue Ala-128 of the b subunit of Escherichia coli ATP synthase to aspartate on the structure of the subunit and its interaction with the F(1) sector were analyzed. Determination of solution molecular weights by sedimentation equilibrium ultracentrifugation revealed that the A128D mutation had little effect on dimerization in the soluble b construct, b(34-156). However, the mutation caused a structural perturbation detected through both a 12% reduction in the sedimentation coefficient and also a reduced tendency to form intersubunit disulfide bonds between cysteine residues inserted at position 132. Unlike the wild-type sequence, the A128D mutant was unable to interact with F(1)-ATPase. These results indicate that the A128D mutation caused a structural change in the C-terminal region of the protein, preventing the binding to F(1) but having little or no effect on the dimeric nature of b.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004471     DOI: 10.1016/s0005-2728(00)00192-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

Review 1.  The b subunit of Escherichia coli ATP synthase.

Authors:  S D Dunn; M Revington; D J Cipriano; B H Shilton
Journal:  J Bioenerg Biomembr       Date:  2000-08       Impact factor: 2.945

2.  Folding and stability of the b subunit of the F(1)F(0) ATP synthase.

Authors:  Matthew Revington; Stanley D Dunn; Gary S Shaw
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

3.  Manipulating the length of the b subunit F1 binding domain in F1F0 ATP synthase from Escherichia coli.

Authors:  Deepa Bhatt; Stephanie P Cole; Tammy Bohannon Grabar; Shane B Claggett; Brian D Cain
Journal:  J Bioenerg Biomembr       Date:  2005-04       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.